ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shares were up 1.4% during mid-day trading on Friday . The company traded as high as $22.35 and last traded at $22.35. Approximately 100 shares were traded during trading, a decline of 82% from the average daily volume of 559 shares. The stock had previously closed at $22.05.
ALK-Abelló A/S Stock Up 1.4 %
The firm has a 50 day simple moving average of $23.24 and a 200 day simple moving average of $22.85.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Recommended Stories
- Five stocks we like better than ALK-Abelló A/S
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- 3 Warren Buffett Stocks to Buy Now
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Why Invest in 5G? How to Invest in 5G Stocks
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
